Malaria Derived Glycosylphosphatidylinositol Anchor Enhances Anti-Pfs25 Functional Antibodies That Block Malaria Transmission-Reference-Cited by-同舟云学术

Malaria Derived Glycosylphosphatidylinositol Anchor Enhances Anti-Pfs25 Functional Antibodies That Block Malaria Transmission

Published:2018-01-16 Issue:5 Volume:57 Page:516-519
ISSN:0006-2960
Container-title:Biochemistry
language:en
Short-container-title:Biochemistry

Author:

Kapoor Neeraj¹,Vanjak Ivana¹,Rozzelle James¹,Berges Aym¹,Chan Wei¹,Yin Gang²,Tran Cuong²,Sato Aaron K.²,Steiner Alexander R.²,Pham Thao P.³,Birkett Ashley J.⁴,Long Carole A.³,Fairman Jeff¹,Miura Kazutoyo³^ORCID

Affiliation:

1. SutroVax, Inc., 353 Hatch Drive, Foster City, California 94404, United States

2. Sutro Biopharma, 310 Utah, South San Francisco, California 94080, United States

3. Laboratory of Malaria and Vector Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, Maryland 20852, United States

4. PATH’s Malaria Vaccine Initiative (MVI), Washington, D.C. 20001 United States

Funder

PATH

National Institute of Allergy and Infectious Diseases

Publisher

American Chemical Society (ACS)

Subject

Biochemistry

Link

http://pubs.acs.org/doi/pdf/10.1021/acs.biochem.7b01099

Reference29 articles.

1. World Health Organization;World Malaria Report, 2016.